
Peoples Bancorp Financial Ratios 2025-2008 | PEBO
Brief overview of Peoples Bancorp 's multiples and efficiency
The comparison uses the five latest available annual observations between 2021 and 2025.
Market valuation is represented by P/E 10.87x (median 9.42x), P/B 0.96x (median 0.96x), P/CF 8.61x (median 7.18x). Multiples are on average 15.4% above their own medians. A substantial share of positive expectations may already be priced in.
The inverse P/E implies an earnings yield of 9.2%. This is not a dividend yield, but current earnings relative to market price.
End-period return metrics are ROE 8.8%, ROA 1.1%, ROCE 11.2%. Profitability remains low. Market valuation has limited fundamental support until resource returns improve.
PEG is 1.33x. Price relative to expected growth is in a moderate range.
High leverage is part of the financial-sector model, so valuation should be linked to capital, asset quality and ROE.
Overall assessment
Peoples Bancorp 's profile looks stretched: price anticipates improvement that current quality ratios do not yet confirm.
Annual Financial Ratios Peoples Bancorp
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
10.9 | 9.4 | 8.0 | 8.5 | 15.2 | 16.7 | 12.6 | 13.2 | 16.8 | 17.9 | 27.5 | 16.7 | 13.7 | 10.2 | 11.8 | 23.9 | 41.7 | - |
P/S |
13.4 | 13.0 | 11.4 | 12.3 | 11.8 | 3.0 | 3.4 | 3.4 | 4.0 | 3.7 | 2.2 | 2.7 | 2.7 | 2.4 | 1.7 | - | - | - |
EPS |
3.0 | 3.3 | 3.5 | 3.6 | 2.2 | 1.7 | 2.6 | 2.4 | 2.1 | 1.7 | 0.6 | 1.4 | 1.6 | 1.9 | 1.1 | 0.3 | 0.2 | - |
EV (Enterprise Value) |
9.41 B | 9.03 B | 8.59 B | 7.13 B | 6.53 B | 4.61 B | 4.32 B | 4 B | 3.7 B | 3.49 B | 3.07 B | 2.44 B | 2.03 B | 1.84 B | 1.7 B | 1.68 B | 133 M | -35.6 M |
EBITDA per Share |
4.27 | 4.4 | 4.57 | 5.23 | 3.74 | 3.46 | - | - | - | - | - | - | - | - | - | 2.07 | 0.7 | - |
EV/EBITDA |
63.1 | 59.0 | 57.7 | 48.8 | 79.9 | 3.6 | - | - | - | - | - | - | - | - | - | 77.9 | 18.4 | - |
PEG |
1.9 | - | - | - | - | -0.49 | 1.33 | 0.93 | 0.72 | 0.1 | -0.51 | -0.95 | -0.93 | 0.17 | 0.1 | - | - | - |
P/B |
1.0 | 1.0 | 0.9 | 1.1 | 0.9 | 1.0 | 1.1 | 1.2 | 1.4 | 1.3 | 0.7 | 0.8 | 1.1 | 0.9 | 0.7 | 0.6 | - | - |
P/CF |
8.6 | 7.7 | 6.3 | 7.2 | 4.6 | 6.8 | 10.5 | 8.6 | 11.6 | 10.2 | 7.8 | 11.4 | 7.1 | 5.7 | 3.5 | 3.0 | 7.5 | - |
ROE % |
8.85 | 10.54 | 10.76 | 12.90 | 5.63 | 6.04 | 9.03 | 8.89 | 8.39 | 7.16 | 2.61 | 4.91 | 7.93 | 9.19 | 6.08 | 2.70 | 1.72 | - |
ROA % |
1.11 | 1.27 | 1.24 | 1.41 | 0.67 | 0.73 | 1.23 | 1.16 | 1.07 | 0.91 | 0.34 | 0.65 | 0.85 | 1.06 | 0.70 | 0.30 | - | - |
ROCE % |
11.17 | 13.45 | 13.78 | 16.38 | 6.74 | 7.41 | - | - | - | - | - | - | - | - | - | 2.78 | 1.28 | - |
Current Ratio |
1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 1.1 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Peoples Bancorp
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.79 | 0.82 | 0.83 | 0.6 | 0.69 | 0.9 | 0.83 | 0.85 | 0.91 | 0.64 | 0.95 | - | 0.93 | 0.89 | 0.84 | - | -0.28 | 0.52 | 0.8 | 1.06 | 0.52 | 0.7 | -0.04 | 0.72 | 0.72 | 0.47 | 0.74 | 0.71 | 0.65 | 0.41 | 0.64 | 0.5 | 0.6 | 0.54 | 0.49 | 0.41 | 0.43 | 0.44 | 0.44 | 0.14 | 0.23 | 0.27 | -0.04 | 0.29 | 0.33 | 0.32 | 0.45 | 0.48 | 0.24 | 0.46 | 0.47 | 0.36 | 0.45 | 0.47 | 0.63 | 0.33 | 0.35 | 0.26 | 0.13 |
EBITDA per Share |
1.06 | 1.11 | 1.15 | 0.85 | 0.96 | 1.26 | 1.11 | 1.17 | 1.26 | 0.92 | 1.27 | - | 1.27 | 1.21 | 1.12 | - | -0.32 | 0.72 | 1.03 | 0.05 | 0.7 | 1.01 | -0.01 | 0.04 | 0.94 | 0.62 | 0.95 | 0.04 | 0.85 | 0.51 | 0.82 | 0.05 | 0.94 | 0.83 | 0.75 | 0.06 | 0.69 | 0.69 | 0.7 | 0.06 | 0.37 | 0.46 | -0.01 | 0.04 | 0.5 | 0.5 | 0.68 | 0.03 | 0.67 | 0.72 | 0.71 | 0.02 | 0.69 | 0.72 | 0.94 | 0.01 | 0.57 | 0.38 | 0.24 |
ROE % |
8.98 | 8.86 | 9.29 | 9.49 | 10.43 | 11.50 | 10.80 | 11.35 | 11.98 | 11.93 | 12.74 | 9.50 | 8.80 | 7.11 | 6.62 | 3.70 | 7.28 | 9.77 | 10.51 | 7.71 | 6.63 | 7.33 | 6.48 | 9.03 | 9.21 | 9.15 | 9.05 | 8.89 | 8.18 | 8.11 | 8.73 | 8.39 | 8.13 | 7.54 | 7.24 | 7.16 | 6.07 | 5.27 | 4.61 | 2.61 | 3.24 | 3.48 | 3.33 | 4.91 | 5.97 | 5.87 | 7.07 | 7.93 | 7.37 | 8.41 | 8.46 | 9.19 | 9.31 | 9.03 | 8.17 | 6.08 | 1.90 | 1.41 | 0.90 |
ROA % |
1.12 | 1.09 | 1.14 | 1.15 | 1.24 | 1.34 | 1.23 | 1.28 | 1.33 | 1.30 | 0.98 | 0.61 | 0.81 | 0.44 | 0.74 | 0.42 | 0.85 | 1.14 | 1.24 | 0.92 | 0.83 | 0.96 | 0.89 | 1.23 | 1.24 | 1.22 | 1.19 | 1.16 | 1.06 | 1.05 | 1.12 | 1.07 | 1.04 | 0.96 | 0.92 | 0.91 | 0.77 | 0.67 | 0.59 | 0.34 | 0.42 | 0.46 | 0.44 | 0.65 | 0.73 | 0.69 | 0.80 | 0.85 | 0.81 | 0.94 | 0.96 | 1.06 | 1.08 | 1.04 | 0.94 | 0.70 | 0.22 | 0.16 | 0.10 |
ROCE % |
11.55 | 11.42 | 11.98 | 12.10 | 13.28 | 14.63 | 13.72 | 14.49 | 15.32 | 15.25 | 16.18 | 12.08 | 11.12 | 8.87 | 8.16 | 4.50 | 6.77 | 10.82 | 8.52 | 5.20 | 8.25 | 7.98 | 7.87 | 8.03 | 11.02 | 9.68 | 10.40 | 7.42 | 10.91 | 11.01 | 12.06 | 9.35 | 11.98 | 11.11 | 10.70 | 7.94 | 9.25 | 8.32 | 5.49 | 2.81 | 4.55 | 4.72 | 5.06 | 5.26 | 8.37 | 9.99 | 11.82 | 9.78 | 13.00 | 13.27 | 14.30 | 10.99 | 13.80 | 12.43 | 10.19 | 5.79 | 2.81 | 1.84 | 1.14 |
Current Ratio |
1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | - | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Peoples Bancorp , allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.